NABOTA 100IU

NABOTA Prabotulinumtoxin A (Botulinum Toxin Type A)

Botulinum Toxin Type A (Nabota) is indicated for the temporary treatment of glabellar lines associated with corrugators and/or procerus muscle activity in adult patients below 65 years of age. Botulinum Toxin Type A (Nabota) is indicated for the treatment of focal hyperhidrosis of the axilla.

Description

Botulinum Toxin Type A (Nabota) is indicated for the temporary improvement in the appearance of upper facial rhytides (glabellar lines, crow’s feet, and forehead lines) in adults. Botulinum Toxin Type A (Nabota) is indicated for the prophylaxis of headaches in adults with chronic migraine.

Botulinum Toxin Type A (Nabota) is indicated for the treatment of urinary incontinence due to neurogenic detrusor overactivity e.g., spinal cord injury (SCI) or multiple sclerosis (MI) in adults.

INDICATION

·         Temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients (Approved in KR, US, EU, Canada)

·         Treatment of upper limb spasticity in adult patients (Approved in KR)

·         A temporary improvement in the appearance of moderate to severe lateral canthal lines associated with orbicularis oculi activity in adult patients (Approved in KR)

·         Treatment of blepharospasm associated with dystonia in adult patients (Approved in KR)

·         HI PureTM Technology